Pilot randomised controlled trial of a novel form of exercise on parkinsonism symptoms
This pilot trial indicates that the <i>Reviver</i> is a safe and well-tolerated exercise-assistance intervention. The <i>Reviver</i> showed some indications of benefit in our secondary measures for PD participants, but not in our primary outcome. This was a small sample, short duration pilot study, and further studies with larger samples and higher exercise volume are warranted to fully assess the safety and efficacy of the device.
Authors
- Sue Varley
- Joanne Fielding (ORCID: https://orcid.org/0000-0002-1131-0587)
- Brendan P. Major (ORCID: https://orcid.org/0000-0003-0991-5656)
- Evelyn Lindsay
- Terence O’Brien (ORCID: https://orcid.org/0000-0002-2618-814X)
- Lily Turner
- Sahan Muthuhetti Gamage
- Frederique Boonstra
- Benjamin Sinclair (ORCID: https://orcid.org/0000-0002-0850-3644)
- Kelly Bertram (ORCID: https://orcid.org/0000-0002-4283-1182)
- Meaghan Clough (ORCID: https://orcid.org/0000-0001-5962-3681)
- Sarah Fan
- Scott Kolbe (ORCID: https://orcid.org/0000-0003-4685-1380)
- Lucy E. Vivash (ORCID: https://orcid.org/0000-0002-1182-0907)
- Jasmine Moses (ORCID: https://orcid.org/0000-0001-8398-1227)
- Natasha Anne Lannin (ORCID: https://orcid.org/0000-0002-2066-8345)
- Owen White (ORCID: https://orcid.org/0000-0002-2836-7344)
- Meng Law
- Huiliang M Tang
Institutions
- The Alfred Hospital (AU)
- Monash University (AU)
Publication Details
- Journal
- BMJ Neurology Open
- Published
- 2026-01-01
- DOI
- https://doi.org/10.1136/bmjno-2025-001248
- Citations
- 1
- Primary Topic
- Balance, Gait, and Falls Prevention
- Type
- article
- Field-Weighted Citation Impact
- 60.11
Funders
- Biogen
- LivaNova
- National Imaging Facility
- Equity Trustees
- Commonwealth Scientific and Industrial Research Organisation
- Eisai
- Ipsen
- National Institutes of Health
- National Health and Medical Research Council